Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Terumo Corporation · Predicate Candidate Screening

13 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

146 daysmedian FDA review time
247 days90th percentile
13clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K252295RyureiTerumo Corporation2026-03-272470
K250700Pen Injector Needle 32.5Terumo Corporation2025-11-212590
K250751DualView CatheterTerumo Corporation2025-07-171270
K240818R2P Radifocus Glidewire AdvantageTerumo Corporation2024-11-262460
K240859Glidewire GT-RTerumo Corporation2024-08-211460
K190427ImmuciseTerumo Corporation2019-07-181460
K181369Immucise Intradermal Injection SystemTerumo Corporation2018-11-131740
K173799NaviCross 0.018Terumo Corporation2018-03-291050
K170417Glidewire GTTerumo Corporation2017-09-152170
K130280CAPIOX FX HOLLOW FIBER OXYGENATOR W/ RESERVOIRTerumo Corporation2013-03-13360
K130493CAPIOX RX05 HOLLOW FIBER OXYGENATOR/RESERVOIRTerumo Corporation2013-03-13150
K122544TERUMO SURFLASH SAFETY I.V. CATHETERTerumo Corporation2012-09-05150
K113335HEARTRAIL III GUIDING CATHETERTerumo Corporation2012-07-162450

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams: atlasbyauro.com/fda